Bang Nguyen1, Charles Du1, Tarun Bastiampillai2, Rohan Dhillon3, Prashant Tibrewal4. 1. Medical Student, University of Adelaide, Adelaide, SA, Australia. 2. Executive Director, Mental Health Strategy, SA Health, Government of South Australia, Adelaide, SA, and; Mental Health Systems Research, Department of Psychiatry, Flinders University, Bedford Park, SA, and; SAHMRI - Mind & Brain Research Fellow. 3. Medical Lead, Western Mental Health Services, CALHN, Cramond Clinic, The Queen Elizabeth Hospital, Woodville, SA Australia. 4. Consultant Psychiatrist, Cramond Clinic, The Queen Elizabeth Hospital, Woodville, SA, Australia.
Abstract
OBJECTIVE: To explore the evidence around clozapine re-challenge following myocarditis. CONCLUSION: This case adds to the 17 cases of clozapine re-challenge following myocarditis, of which 71% were successful (12 cases). This demonstrates that re-challenge could be performed safely and effectively in the context of clozapine-induced myocarditis, if accompanied by a strict and rigorous monitoring protocol.
OBJECTIVE: To explore the evidence around clozapine re-challenge following myocarditis. CONCLUSION: This case adds to the 17 cases of clozapine re-challenge following myocarditis, of which 71% were successful (12 cases). This demonstrates that re-challenge could be performed safely and effectively in the context of clozapine-induced myocarditis, if accompanied by a strict and rigorous monitoring protocol.